 | • レポートコード：MRC2305B180 • 出版社/出版日：360iResearch / 2022年10月 • レポート形態：英語、PDF、254ページ • 納品方法：Eメール（受注後2-3日） • 産業分類：バイオ |
| Single User（1名利用、印刷可） | ￥742,350 (USD4,949) | ▷ お問い合わせ |
| Enterprise License（企業利用、印刷可） | ￥1,492,350 (USD9,949) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 360iResearch社は、2021年に165.0億ドルであった世界のマイクロ流体力学市場規模が、2022年には205.0億ドルに達し、2027年までに年平均24.78％成長して623.2億ドルになると予測しています。当調査資料では、マイクロ流体力学の世界市場について調査・分析を行い、序論、調査方法、エグゼクティブサマリー、市場概要、市場インサイト、材料別分析（ガラスベース、ポリマーベース、シリコンベース）、コンポーネント別分析（マイクロニードル、マイクロポンプ、マイクロ流体チップ）、用途別分析（体外診断、製薬＆ライフサイエンス研究、治療）、エンドユーザー別分析（学術＆研究機関、病院＆診断センター、製薬＆バイオテクノロジー企業）、地域別分析（南北アメリカ、アメリカ、カナダ、ブラジル、アジア太平洋、日本、中国、インド、韓国、台湾、ヨーロッパ/中東/アフリカ、イギリス、ドイツ、フランス、ロシア、その他）、競争状況、企業情報などの項目をまとめました。なお、当書に掲載されている企業情報には、Abaxis, Inc.、Abbott Laboratories、Agilent Technologies, Inc.、Bio-Rad Laboratories, Inc.、Camozzi Automation S.p.A.、Cellix Limited、Danaher Corporation、Dolomite Microfluidics、Elveflow by Elvesys Group、Fluidigm Corporationなどが含まれています。 ・序論 ・調査方法 ・エグゼクティブサマリー ・市場概要 ・市場インサイト ・世界のマイクロ流体力学市場規模：材料別 - ガラスベースマイクロ流体力学の市場規模 - ポリマーベースマイクロ流体力学の市場規模 - シリコンベースマイクロ流体力学の市場規模 ・世界のマイクロ流体力学市場規模：コンポーネント別 - マイクロニードルの市場規模 - マイクロポンプの市場規模 - マイクロ流体チップの市場規模 ・世界のマイクロ流体力学市場規模：用途別 - 体外診断における市場規模 - 製薬＆ライフサイエンス研究における市場規模 - 治療における市場規模 ・世界のマイクロ流体力学市場規模：エンドユーザー別 - 学術＆研究機関における市場規模 - 病院＆診断センターにおける市場規模 - 製薬＆バイオテクノロジー企業における市場規模 ・世界のマイクロ流体力学市場規模：地域別 - 南北アメリカのマイクロ流体力学市場規模 アメリカのマイクロ流体力学市場規模 カナダのマイクロ流体力学市場規模 ブラジルのマイクロ流体力学市場規模 ... - アジア太平洋のマイクロ流体力学市場規模 日本のマイクロ流体力学市場規模 中国のマイクロ流体力学市場規模 インドのマイクロ流体力学市場規模 韓国のマイクロ流体力学市場規模 台湾のマイクロ流体力学市場規模 ... - ヨーロッパ/中東/アフリカのマイクロ流体力学市場規模 イギリスのマイクロ流体力学市場規模 ドイツのマイクロ流体力学市場規模 フランスのマイクロ流体力学市場規模 ロシアのマイクロ流体力学市場規模 ... - その他地域のマイクロ流体力学市場規模 ・競争状況 ・企業情報 |
The Global Microfluidics Market size was estimated at USD 16.50 billion in 2021 and expected to reach USD 20.50 billion in 2022, and is projected to grow at a CAGR 24.78% to reach USD 62.32 billion by 2027.
Market Statistics:
The report provides market sizing and forecast across 7 major currencies – USD, EUR, JPY, GBP, AUD, CAD, and CHF. It helps organization leaders make better decisions when currency exchange data is readily available. In this report, the years 2018 and 2020 are considered as historical years, 2021 as the base year, 2022 as the estimated year, and years from 2023 to 2027 are considered as the forecast period.
Market Segmentation & Coverage:
This research report categorizes the Microfluidics to forecast the revenues and analyze the trends in each of the following sub-markets:
Based on Material, the market was studied across Glass-based, Polymer-based, and Silicon-based.
Based on Component, the market was studied across Micro Needle, Micro Pump, and Microfluidic Chip.
Based on Application, the market was studied across In-Vitro Diagnostics, Pharmaceutical & Life Science Research, and Therapeutics. The In-Vitro Diagnostics is further studied across Clinical Diagnostics, Point-Of-Care Testing, and Veterinary Diagnostics. The Pharmaceutical & Life Science Research is further studied across Lab Analytics, Microdispensing, and Microreaction. The Lab Analytics is further studied across Capillary Electrophoresis, Cell-based Assays, Genomic analysis, and Proteomic Analysis. The Therapeutics is further studied across Drug Delivery and Wearable Devices.
Based on End User, the market was studied across Academic & Research Institutes, Hospitals & Diagnostic Centers, and Pharmaceutical & Biotechnology Companies.
Based on Region, the market was studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Connecticut, Florida, Illinois, Maryland, Minnesota, New Jersey, New York, Ohio, Pennsylvania, Texas, and Washington. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom.
Cumulative Impact of COVID-19:
COVID-19 is an incomparable global public health emergency that has affected almost every industry, and the long-term effects are projected to impact the industry growth during the forecast period. Our ongoing research amplifies our research framework to ensure the inclusion of underlying COVID-19 issues and potential paths forward. The report delivers insights on COVID-19 considering the changes in consumer behavior and demand, purchasing patterns, re-routing of the supply chain, dynamics of current market forces, and the significant interventions of governments. The updated study provides insights, analysis, estimations, and forecasts, considering the COVID-19 impact on the market.
Cumulative Impact of 2022 Russia Ukraine Conflict:
We continuously monitor and update reports on political and economic uncertainty due to the Russian invasion of Ukraine. Negative impacts are significantly foreseen globally, especially across Eastern Europe, European Union, Eastern & Central Asia, and the United States. This contention has severely affected lives and livelihoods and represents far-reaching disruptions in trade dynamics. The potential effects of ongoing war and uncertainty in Eastern Europe are expected to have an adverse impact on the world economy, with especially long-term harsh effects on Russia.This report uncovers the impact of demand & supply, pricing variants, strategic uptake of vendors, and recommendations for Microfluidics market considering the current update on the conflict and its global response.
Competitive Strategic Window:
The Competitive Strategic Window analyses the competitive landscape in terms of markets, applications, and geographies to help the vendor define an alignment or fit between their capabilities and opportunities for future growth prospects. It describes the optimal or favorable fit for the vendors to adopt successive merger and acquisition strategies, geography expansion, research & development, and new product introduction strategies to execute further business expansion and growth during a forecast period.
FPNV Positioning Matrix:
The FPNV Positioning Matrix evaluates and categorizes the vendors in the Microfluidics Market based on Business Strategy (Business Growth, Industry Coverage, Financial Viability, and Channel Support) and Product Satisfaction (Value for Money, Ease of Use, Product Features, and Customer Support) that aids businesses in better decision making and understanding the competitive landscape.
Market Share Analysis:
The Market Share Analysis offers the analysis of vendors considering their contribution to the overall market. It provides the idea of its revenue generation into the overall market compared to other vendors in the space. It provides insights into how vendors are performing in terms of revenue generation and customer base compared to others. Knowing market share offers an idea of the size and competitiveness of the vendors for the base year. It reveals the market characteristics in terms of accumulation, fragmentation, dominance, and amalgamation traits.
Competitive Scenario:
The Competitive Scenario provides an outlook analysis of the various business growth strategies adopted by the vendors. The news covered in this section deliver valuable thoughts at the different stage while keeping up-to-date with the business and engage stakeholders in the economic debate. The competitive scenario represents press releases or news of the companies categorized into Merger & Acquisition, Agreement, Collaboration, & Partnership, New Product Launch & Enhancement, Investment & Funding, and Award, Recognition, & Expansion. All the news collected help vendor to understand the gaps in the marketplace and competitor’s strength and weakness thereby, providing insights to enhance product and service.
Company Usability Profiles:
The report profoundly explores the recent significant developments by the leading vendors and innovation profiles in the Global Microfluidics Market, including Abaxis, Inc., Abbott Laboratories, Agilent Technologies, Inc., Bio-Rad Laboratories, Inc., Camozzi Automation S.p.A., Cellix Limited, Danaher Corporation, Dolomite Microfluidics, Elveflow by Elvesys Group, Fluidigm Corporation, Fluigent S.A., Idex Corporation, Illumina, Inc., IMT Masks and Divisions AG, Koninklijke Philips N.V., Parker-Hannifin Corporation, PerkinElmer Inc., SMC Corporation, and Thermo Fisher Scientific, Inc..
The report provides insights on the following pointers:
1. Market Penetration: Provides comprehensive information on the market offered by the key players
2. Market Development: Provides in-depth information about lucrative emerging markets and analyze penetration across mature segments of the markets
3. Market Diversification: Provides detailed information about new product launches, untapped geographies, recent developments, and investments
4. Competitive Assessment & Intelligence: Provides an exhaustive assessment of market shares, strategies, products, certification, regulatory approvals, patent landscape, and manufacturing capabilities of the leading players
5. Product Development & Innovation: Provides intelligent insights on future technologies, R&D activities, and breakthrough product developments
The report answers questions such as:
1. What is the market size and forecast of the Global Microfluidics Market?
2. What are the inhibiting factors and impact of COVID-19 shaping the Global Microfluidics Market during the forecast period?
3. Which are the products/segments/applications/areas to invest in over the forecast period in the Global Microfluidics Market?
4. What is the competitive strategic window for opportunities in the Global Microfluidics Market?
5. What are the technology trends and regulatory frameworks in the Global Microfluidics Market?
6. What is the market share of the leading vendors in the Global Microfluidics Market?
7. What modes and strategic moves are considered suitable for entering the Global Microfluidics Market?
1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Limitations
1.7. Assumptions
1.8. Stakeholders
2. Research Methodology
2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update
3. Executive Summary
4. Market Overview
5. Market Insights
5.1. Market Dynamics
5.1.1. Drivers
5.1.1.1. Growing Incidence of Chronic Diseases and Increasing Demand for Point-Of-Care Testing
5.1.1.2. Improved Portability of Devices through Microfluidic Chip Miniaturization and Faster Turn-Around Time for Analysis
5.1.1.3. Potential Applications of Drug Delivery using Microfluidics
5.1.2. Restraints
5.1.2.1. Complicated and Time-Consuming Regulatory Approval Process
5.1.3. Opportunities
5.1.3.1. Development of Microfluidic-Based 3D Cell Culture Systems such as Organ-on-a-Chip
5.1.3.2. Advances in Microfluidic Components for Biomedical Analysis and Diagnostics
5.1.4. Challenges
5.1.4.1. Integration of Microfluidics with Existing Workflows
5.2. Cumulative Impact of COVID-19
6. Microfluidics Market, by Material
6.1. Introduction
6.2. Glass-based
6.3. Polymer-based
6.4. Silicon-based
7. Microfluidics Market, by Component
7.1. Introduction
7.2. Micro Needle
7.3. Micro Pump
7.4. Microfluidic Chip
8. Microfluidics Market, by Application
8.1. Introduction
8.2. In-Vitro Diagnostics
8.3.1. Clinical Diagnostics
8.3.2. Point-Of-Care Testing
8.3.3. Veterinary Diagnostics
8.3. Pharmaceutical & Life Science Research
8.4.1. Lab Analytics
8.4.2.1. Capillary Electrophoresis
8.4.2.2. Cell-based Assays
8.4.2.3. Genomic analysis
8.4.2.4. Proteomic Analysis
8.4.2. Microdispensing
8.4.3. Microreaction
8.4. Therapeutics
8.5.1. Drug Delivery
8.5.2. Wearable Devices
9. Microfluidics Market, by End User
9.1. Introduction
9.2. Academic & Research Institutes
9.3. Hospitals & Diagnostic Centers
9.4. Pharmaceutical & Biotechnology Companies
10. Americas Microfluidics Market
10.1. Introduction
10.2. Argentina
10.3. Brazil
10.4. Canada
10.5. Mexico
10.6. United States
11. Asia-Pacific Microfluidics Market
11.1. Introduction
11.2. Australia
11.3. China
11.4. India
11.5. Indonesia
11.6. Japan
11.7. Malaysia
11.8. Philippines
11.9. Singapore
11.10. South Korea
11.11. Taiwan
11.12. Thailand
11.13. Vietnam
12. Europe, Middle East & Africa Microfluidics Market
12.1. Introduction
12.2. Denmark
12.3. Egypt
12.4. Finland
12.5. France
12.6. Germany
12.7. Israel
12.8. Italy
12.9. Netherlands
12.10. Nigeria
12.11. Norway
12.12. Poland
12.13. Qatar
12.14. Russia
12.15. Saudi Arabia
12.16. South Africa
12.17. Spain
12.18. Sweden
12.19. Switzerland
12.20. Turkey
12.21. United Arab Emirates
12.22. United Kingdom
13. Competitive Landscape
13.1. FPNV Positioning Matrix
13.1.1. Quadrants
13.1.2. Business Strategy
13.1.3. Product Satisfaction
13.2. Market Ranking Analysis, By Key Player
13.3. Market Share Analysis, By Key Player
13.4. Competitive Scenario
13.4.1. Merger & Acquisition
13.4.2. Agreement, Collaboration, & Partnership
13.4.3. New Product Launch & Enhancement
13.4.4. Investment & Funding
13.4.5. Award, Recognition, & Expansion
14. Company Usability Profiles
14.1. Abaxis, Inc.
14.1.1. Business Overview
14.1.2. Key Executives
14.1.3. Product & Services
14.2. Abbott Laboratories
14.2.1. Business Overview
14.2.2. Key Executives
14.2.3. Product & Services
14.3. Agilent Technologies, Inc.
14.3.1. Business Overview
14.3.2. Key Executives
14.3.3. Product & Services
14.4. Bio-Rad Laboratories, Inc.
14.4.1. Business Overview
14.4.2. Key Executives
14.4.3. Product & Services
14.5. Camozzi Automation S.p.A.
14.5.1. Business Overview
14.5.2. Key Executives
14.5.3. Product & Services
14.6. Cellix Limited
14.6.1. Business Overview
14.6.2. Key Executives
14.6.3. Product & Services
14.7. Danaher Corporation
14.7.1. Business Overview
14.7.2. Key Executives
14.7.3. Product & Services
14.8. Dolomite Microfluidics
14.8.1. Business Overview
14.8.2. Key Executives
14.8.3. Product & Services
14.9. Elveflow by Elvesys Group
14.9.1. Business Overview
14.9.2. Key Executives
14.9.3. Product & Services
14.10. Fluidigm Corporation
14.10.1. Business Overview
14.10.2. Key Executives
14.10.3. Product & Services
14.11. Fluigent S.A.
14.11.1. Business Overview
14.11.2. Key Executives
14.11.3. Product & Services
14.12. Idex Corporation
14.12.1. Business Overview
14.12.2. Key Executives
14.12.3. Product & Services
14.13. Illumina, Inc.
14.13.1. Business Overview
14.13.2. Key Executives
14.13.3. Product & Services
14.14. IMT Masks and Divisions AG
14.14.1. Business Overview
14.14.2. Key Executives
14.14.3. Product & Services
14.15. Koninklijke Philips N.V.
14.15.1. Business Overview
14.15.2. Key Executives
14.15.3. Product & Services
14.16. Parker-Hannifin Corporation
14.16.1. Business Overview
14.16.2. Key Executives
14.16.3. Product & Services
14.17. PerkinElmer Inc.
14.17.1. Business Overview
14.17.2. Key Executives
14.17.3. Product & Services
14.18. SMC Corporation
14.18.1. Business Overview
14.18.2. Key Executives
14.18.3. Product & Services
14.19. Thermo Fisher Scientific, Inc.
14.19.1. Business Overview
14.19.2. Key Executives
14.19.3. Product & Services
15. Appendix
15.1. Discussion Guide
15.2. License & Pricing